BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Pharm Country

  Nymox Pharmaceutical Announces $13 Million Equity Financing

  November 2, 2005

   · 

  1 min read
• BioMidwest

  MEDTOX Scientific Receives FDA 510(k) Clearance For Its New Sure-Screen(R) Device

  November 2, 2005

   · 

  1 min read
• Biotech Bay

  HemoSense, Inc. Announces Approximately $10 Million Private Placement

  November 2, 2005

   · 

  1 min read
• Business

  Applied InSilico Announces Its First Top Five Pharmaceutical Customer; GlaxoSmithKline Licenses ELE(TM) Evolutionary Learning Environment

  November 2, 2005

   · 

  1 min read
• Business

  Advanced Medical Optics, Inc. Says Board Speeds Up Restructuring

  November 2, 2005

   · 

  1 min read
• Drug Development

  BioSante Pharmaceuticals, Inc. Comments On Updated FDA Guidance For Testosterone Therapy

  November 2, 2005

   · 

  1 min read
• Drug Development

  New Clinical Data On Ariad Pharmaceuticals, Inc. Novel mTOR Inhibitor, AP23573, To Be Presented At Upcoming Oncology Meetings

  November 2, 2005

   · 

  1 min read
• Drug Development

  Forbes Medi-Tech Initiates US Phase II Trial For Cholesterol-Lowering Drug, FM-VP4

  November 2, 2005

   · 

  1 min read
• Drug Development

  Androclus Therapeutics Reports Completion Of A Phase 2 Clinical Trial Of AT-001 In Patients With Rheumatoid Arthritis

  November 2, 2005

   · 

  1 min read
• Deals

  Johnson & Johnson Receives FTC Clearance Of Proposed Acquisition Of Guidant Corporation And Provides Update On Transaction In Light Of Guidant Recall Events

  November 2, 2005

   · 

  2 min read